PL3848025T3 - Kompozycje zawierające aminokwasy do zastosowania w zapobieganiu i leczeniu skutków ubocznych chemioterapii - Google Patents
Kompozycje zawierające aminokwasy do zastosowania w zapobieganiu i leczeniu skutków ubocznych chemioterapiiInfo
- Publication number
- PL3848025T3 PL3848025T3 PL20216079.2T PL20216079T PL3848025T3 PL 3848025 T3 PL3848025 T3 PL 3848025T3 PL 20216079 T PL20216079 T PL 20216079T PL 3848025 T3 PL3848025 T3 PL 3848025T3
- Authority
- PL
- Poland
- Prior art keywords
- prevention
- compositions
- treatment
- amino acids
- side effects
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102020000000442A IT202000000442A1 (it) | 2020-01-13 | 2020-01-13 | Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3848025T3 true PL3848025T3 (pl) | 2023-10-30 |
Family
ID=70009337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20216079.2T PL3848025T3 (pl) | 2020-01-13 | 2020-12-21 | Kompozycje zawierające aminokwasy do zastosowania w zapobieganiu i leczeniu skutków ubocznych chemioterapii |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12472159B2 (pl) |
| EP (1) | EP3848025B9 (pl) |
| JP (1) | JP2023509627A (pl) |
| KR (1) | KR20220128629A (pl) |
| CN (1) | CN114980878A (pl) |
| AU (1) | AU2020423611B2 (pl) |
| BR (1) | BR112022013418A2 (pl) |
| CA (1) | CA3166643A1 (pl) |
| CL (1) | CL2022001780A1 (pl) |
| ES (1) | ES2954594T3 (pl) |
| IT (1) | IT202000000442A1 (pl) |
| MX (1) | MX2022008096A (pl) |
| PL (1) | PL3848025T3 (pl) |
| WO (1) | WO2021144639A1 (pl) |
| ZA (1) | ZA202207728B (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700087359A1 (it) | 2017-07-28 | 2019-01-28 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale |
| IT201800006725A1 (it) | 2018-06-27 | 2019-12-27 | Composizioni comprendenti aminoacidi per l'uso nella prevenzione e nel trattamento di malattie epatiche | |
| IT201900002109A1 (it) | 2019-02-13 | 2020-08-13 | Professional Dietetics Spa | Composizioni comprendenti amminoacidi per l'uso nel trattamento di lesioni del sistema nervoso centrale |
| IT202000000454A1 (it) | 2020-01-13 | 2021-07-13 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro |
| CN113425707B (zh) * | 2021-07-30 | 2022-12-30 | 青岛大学附属医院 | 壬二酸预防蒽环类抗肿瘤药物心肌毒性的应用 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5535049A (en) | 1978-09-04 | 1980-03-11 | Otsuka Pharmaceut Factory Inc | Amino acid transfusion for cancerous patient |
| JPH0873351A (ja) | 1994-06-30 | 1996-03-19 | Ajinomoto Co Inc | 炎症性腸疾患用栄養組成物 |
| US6537969B1 (en) | 1997-10-24 | 2003-03-25 | John P. Blass | Nutritional supplement for cerebral metabolic insufficiencies |
| DE10000577A1 (de) | 2000-01-10 | 2001-07-26 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten |
| ITTO20010804A1 (it) | 2001-08-08 | 2003-02-08 | Professional Dietetics Srl | Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl |
| US6620850B2 (en) | 2001-09-19 | 2003-09-16 | University Of Florida | Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors |
| ITTO20030789A1 (it) | 2003-10-07 | 2005-04-08 | Professional Dietetics Srl | Composizione a base di amino acidi per il trattamento |
| EP1813271A4 (en) | 2004-10-26 | 2008-05-21 | Ajinomoto Kk | PREVENTIVE / THERAPEUTIC AGENT FOR VISCERAL PAIN |
| WO2007049818A1 (ja) | 2005-10-27 | 2007-05-03 | Ajinomoto Co., Inc. | 抗脂肪肝、抗肥満及び抗高脂血症用組成物 |
| US7982066B2 (en) | 2005-12-09 | 2011-07-19 | Novalife, Inc. | High protein supplement |
| JP2007161642A (ja) | 2005-12-14 | 2007-06-28 | Kyowa Hakko Kogyo Co Ltd | アルコール性肝障害抑制剤 |
| JP6000253B2 (ja) | 2010-09-24 | 2016-09-28 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | 胃腸機能を改善するための材料および方法 |
| WO2012111790A1 (ja) | 2011-02-17 | 2012-08-23 | 味の素株式会社 | 化学療法剤の抗腫瘍活性増強剤 |
| TW201311234A (zh) * | 2011-04-28 | 2013-03-16 | Ajinomoto Kk | 抗癌劑副作用改善用組成物 |
| US20130084378A1 (en) | 2011-09-30 | 2013-04-04 | Daesang Corporation | Amino acid seasoning compositions comprising l-glutamic acid and l-lysine |
| US9198454B2 (en) | 2012-03-08 | 2015-12-01 | Nusirt Sciences, Inc. | Compositions, methods, and kits for regulating energy metabolism |
| WO2013188874A1 (en) * | 2012-06-15 | 2013-12-19 | Gencia Corporation | Methods of mitigating side effects of radiation exposure and chemotherapy |
| CN102772407B (zh) | 2012-08-01 | 2014-09-17 | 岳茂兴 | 一种促进神经损伤修复的药物组合物及其应用 |
| US20140243400A1 (en) | 2013-02-28 | 2014-08-28 | University of Alaska Anchorage | Compositions comprising citric acid and malic acid and methods and uses thereof |
| US9597367B2 (en) | 2013-04-19 | 2017-03-21 | Bioventures, Llc | Methods for improving muscle and heart function |
| US10226441B2 (en) | 2014-12-09 | 2019-03-12 | Nihon Sizen Hakkoh Co., Ltd. | Aging inhibitor |
| EP3247343A1 (en) | 2015-01-23 | 2017-11-29 | Nestec S.A. | Nutritional composition useful in the treatment of ibd patients |
| CN105982914A (zh) | 2015-01-30 | 2016-10-05 | 刘力 | 复方氨基酸注射液18aa-i的新药物组合物和用途 |
| MX357998B (es) | 2015-03-20 | 2018-07-11 | Antonio Hernandez Miramontes Jorge | Una mezcla de acidos carboxilicos, especificamente acido citrico, acido succinico, acido fumarico y acido malico para el tratamiento de pacientes con insuficiencia renal cronica, insuficiencia renal aguda, hepatopatias agudas o cronicas que cursen con hiperamonemia, enfermedades congenitas con alteraciones enzimaticas en el ciclo de la urea, asi como condiciones clínicas que cursen con balance nitrogenado negativo. |
| EP3294281A4 (en) | 2015-05-11 | 2019-01-23 | Newcastle Innovation Limited | AMINOSÄURESUPPLMENTIERUNG |
| PL3294279T3 (pl) * | 2015-05-14 | 2020-06-29 | Professional Dietetics International S.R.L. | Kompozycje zawierające aminokwasy do zastosowania w leczeniu zapalenia błony śluzowej u pacjentów cierpiących na neoplazję poddawanych radioterapii i/lub chemioterapii |
| WO2017020121A1 (en) | 2015-07-31 | 2017-02-09 | Val-Chum, Limited Partnership | Glycerol-3-phosphate phosphatase activators |
| EP3379946B1 (en) * | 2015-11-27 | 2024-08-21 | DoubleGood AB | Food supplement and composition for treating the metabolic syndrome |
| WO2018201024A1 (en) | 2017-04-28 | 2018-11-01 | Axcella Health Inc. | Amino acid compositions and their use for the treatment of traumatic brain injury |
| IT201700087376A1 (it) | 2017-07-28 | 2019-01-28 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale |
| IT201700087359A1 (it) | 2017-07-28 | 2019-01-28 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale |
| WO2019070750A1 (en) | 2017-10-02 | 2019-04-11 | University Of Florida Research Foundation , Incorporated | MATERIALS AND METHODS FOR INHIBITING TUMOR GROWTH |
| US20210253985A1 (en) | 2018-02-23 | 2021-08-19 | Ava Food Labs, Inc. | Moscato wine replicas produced from individual components |
| IT201800006725A1 (it) | 2018-06-27 | 2019-12-27 | Composizioni comprendenti aminoacidi per l'uso nella prevenzione e nel trattamento di malattie epatiche | |
| IT201900002109A1 (it) | 2019-02-13 | 2020-08-13 | Professional Dietetics Spa | Composizioni comprendenti amminoacidi per l'uso nel trattamento di lesioni del sistema nervoso centrale |
| IT202000000454A1 (it) | 2020-01-13 | 2021-07-13 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro |
| IT202000018913A1 (it) | 2020-07-31 | 2022-01-31 | Vetagro Int S R L | Composizioni comprendenti timolo e amminoacidi per uso nel trattamento di disturbi intestinali infiammatori o funzionali mediante modulazione del sistema endocannabinoide |
| WO2022266480A1 (en) | 2021-06-17 | 2022-12-22 | Axcella Health Inc. | Methods of predicting liver fat content and uses thereof |
-
2020
- 2020-01-13 IT IT102020000000442A patent/IT202000000442A1/it unknown
- 2020-12-21 BR BR112022013418A patent/BR112022013418A2/pt unknown
- 2020-12-21 CA CA3166643A patent/CA3166643A1/en active Pending
- 2020-12-21 EP EP20216079.2A patent/EP3848025B9/en active Active
- 2020-12-21 WO PCT/IB2020/062291 patent/WO2021144639A1/en not_active Ceased
- 2020-12-21 ES ES20216079T patent/ES2954594T3/es active Active
- 2020-12-21 CN CN202080093098.3A patent/CN114980878A/zh active Pending
- 2020-12-21 JP JP2022540340A patent/JP2023509627A/ja active Pending
- 2020-12-21 US US17/792,380 patent/US12472159B2/en active Active
- 2020-12-21 PL PL20216079.2T patent/PL3848025T3/pl unknown
- 2020-12-21 MX MX2022008096A patent/MX2022008096A/es unknown
- 2020-12-21 AU AU2020423611A patent/AU2020423611B2/en active Active
- 2020-12-21 KR KR1020227025981A patent/KR20220128629A/ko not_active Withdrawn
-
2022
- 2022-06-29 CL CL2022001780A patent/CL2022001780A1/es unknown
- 2022-07-12 ZA ZA2022/07728A patent/ZA202207728B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN114980878A (zh) | 2022-08-30 |
| EP3848025A1 (en) | 2021-07-14 |
| EP3848025B1 (en) | 2023-06-07 |
| ES2954594T3 (es) | 2023-11-23 |
| MX2022008096A (es) | 2022-07-27 |
| AU2020423611B2 (en) | 2025-12-11 |
| KR20220128629A (ko) | 2022-09-21 |
| EP3848025C0 (en) | 2023-06-07 |
| CL2022001780A1 (es) | 2023-02-03 |
| IT202000000442A1 (it) | 2021-07-13 |
| WO2021144639A1 (en) | 2021-07-22 |
| US12472159B2 (en) | 2025-11-18 |
| CA3166643A1 (en) | 2021-07-22 |
| JP2023509627A (ja) | 2023-03-09 |
| US20230067642A1 (en) | 2023-03-02 |
| EP3848025B9 (en) | 2023-08-16 |
| AU2020423611A1 (en) | 2022-07-21 |
| ZA202207728B (en) | 2023-04-26 |
| BR112022013418A2 (pt) | 2022-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202207728B (en) | Compositions comprising amino acids for use in the prevention and treatment of chemotherapy side effects | |
| ZA202007834B (en) | Compositions comprising amino acids for use in the prevention and treatment of liver diseases | |
| PL3848024T3 (pl) | Kompozycje obejmujące aminokwasy do zapobiegania i/lub leczenia nowotworów | |
| SG11201912103TA (en) | Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases | |
| ZA202307970B (en) | Compounds for use in the treatment and prevention of covid- 19 | |
| GB2613460B (en) | Pharmaceutical Compositions for use in methods for the prophylaxis or treatment of COVID such as COVID-19; and compound for use in the treatment of a | |
| MY183462A (en) | A pharmaceutical composition for anaemia | |
| IL289758B2 (en) | Proportin inhibitors for use in the prevention and treatment of kidney injury | |
| ZA202105277B (en) | Compositions comprising amino acids for use and treatment of central nervous system injuries | |
| PL3294279T3 (pl) | Kompozycje zawierające aminokwasy do zastosowania w leczeniu zapalenia błony śluzowej u pacjentów cierpiących na neoplazję poddawanych radioterapii i/lub chemioterapii | |
| LT3658133T (lt) | Kompozicijos, apimančios aminorūgštis, skirtos panaudoti nutukimo gydymui | |
| EP3960167A4 (en) | Use of pantothenic acid in preparation composition for treating and/or preventing tumors | |
| GB202406893D0 (en) | Therapeutic and preventive compositions | |
| PL3768246T3 (pl) | Kompozycje farmaceutyczne sapozyny c i ich zastosowanie w leczeniu nowotworu | |
| PL3829553T3 (pl) | Kompozycja do stosowania do zapobiegania i/lub leczenia śluzówki układu moczowo-płciowego | |
| PL4346847T3 (pl) | Kompleks wielojonowy do stosowania w profilaktyce lub leczeniu zapalenia neurogennego | |
| EP4043027A4 (en) | APPLICATION OF PEG INTERFERON AND PROTO-ONCOGEN TARGETING INHIBITOR IN SYNERGISTIC TREATMENT OF RENAL CARCINOMA | |
| GB2610895C (en) | Composition for use in the treatment and/or prevention of mycotoxic disease | |
| GB202107297D0 (en) | Composition for use in the treatment and/or prevention of mycotoxic disease | |
| CA3260002A1 (en) | COMPOSITIONS COMPRISING AMINO ACIDS INTENDED FOR USE IN THE PREVENTION AND/OR TREATMENT OF INTESTINAL DISEASES | |
| IL294722A (en) | cxcl8 inhibitor and its pharmaceutical composition for use in the treatment of cancer-related fatigue | |
| GB202202541D0 (en) | Composition for use in the treatment and/or prevention of mycotoxic disease | |
| PL3865137T3 (pl) | Kompozycje i ich zastosowanie w leczeniu lub zapobieganiu niewydolności żylnej | |
| IL309196A (en) | GHR-binding peptide and composition containing it | |
| HK40111012A (en) | Compositions and their use for the treatment of alpha1-antitrypsin deficiency |